Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.

No abstract is available for this paper.

• Publication year

  1973

• Venue

  Journal of Neurological Sciences

• Publication date

  1973-12-01

• Fields of study

  Medicine, Physics, Psychology

• Identifiers
  DOI 10.1016/0022-510X(73)90175-5PMID 4272516
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Assay of serotonin and related metabolites, enzymes, and drugs.

  2006cited by this paper
• [Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system].

  1998cited by this paper
• Striatonigral degeneration: Response to levodopa therapy with pathological and neurochemical correlation

  1973cited by this paper
• Neurochemistry of Parkinsonism

  1972cited by this paper
• Handbuch der speziellen pathologischen Anatomie und Histologie

  1972cited by this paper
• OCCURRENCE AND DISTRIBUTION OF AROMATIC l‐AMINO ACID (l‐DOPA) DECARBOXYLASE IN THE HUMAN BRAIN

  1972cited by this paper
• 9 – Dopamine and Its Physiological Significance in Brain Function

  1972cited by this paper
• Nigrostriatal and nigrothalamic fibers in the rhesus monkey

  1972cited by this paper
• [CNS lesions in olivo-ponto-cerebellar atrophies].

  1971cited by this paper
• Nigro-striatal pathway: stimulation-evoked release of ( 3 H)dopamine from caudate nucleus.

  1971cited by this paper
• l-DOPA treatment in Parkinson's disease: Effect on dopamine and related substances in discrete brain regions

  1971cited by this paper
• Monoamines in the human neostriatum: topographic distribution in normals and in Parkinson's disease and their role in akinesia, rigidity, chorea, and tremor.

  1971cited by this paper
• THE RELEASE IN VIVO OF DOPAMINE SYNTHESIZED FROM LABELLED PRECURSORS IN THE CAUDATE NUCLEUS OF THE CAT

  1971cited by this paper
• Anatomical and chemical studies of a nigro-neostriatal projection in the cat.

  1971cited by this paper
• The release of H 3 -dopamine from cat brain following electrical stimulation of the substantia nigra and caudate nucleus.

  1971cited by this paper
• Experimental midbrain lesions: neurochemical comparison between the animal model and Parkinson's disease.

  1971cited by this paper
• [Parkinson's disease concurring with other diseases of the central nervous system].

  1971cited by this paper
• Effect of L-dopa on brain monoamines and their metabolites in Parkinson's disease.

  1971cited by this paper
• Cerebral catecholamines after levodopa therapy.

  1971cited by this paper
• The site of termination of afferent fibres in the caudate nucleus.

  1971cited by this paper
• Cholinesterasic striatopallidal and striatonigral efferents in the cat and the monkey.

  1970cited by this paper
• Possible dopaminergic pathway from substantia nigra to putamen.

  1970cited by this paper
• L-Dopa therapy in Parkinson's disease.

  1970cited by this paper
• Parkinson's Disease: Activity of L-Dopa Decarboxylase in Discrete Brain Regions

  1970cited by this paper
• Striatonigral degeneration. Clinical-pathological correlations and response to stereotaxic surgery.

  1970cited by this paper
• A pharmacologic analysis of Huntington's chorea.

  1970cited by this paper
• Caudate nucleus neurones: correlation of the effects of substantia nigra stimulation with iontophoretic dopamine

  1970cited by this paper
• Distribution of noradrenaline storing particles in peripheral adrenergic neurons as revealed by electron microscopy.

  1969cited by this paper
• Modification of Parkinsonism--chronic treatment with L-dopa.

  1969cited by this paper
• The medial forebrain bundle (MFB) and ascending monoaminergic pathways in the cat.

  1969cited by this paper
• L-dopa therapy in Parkinson's disease: a critical review of nine years' experience.

  1969cited by this paper
• Release into the cerebral ventricles of substances with possible transmitter function in the caudate nucleus

  1969cited by this paper
• Dopamine sites in the basal ganglia.

  1969cited by this paper
• Selective depletion of caudate nucleus dopamine and serotonin during chronic manganese dioxide administration to squirrel monkeys

  1969cited by this paper
• Changes in dopamine levels in the corpus striatum following lesions in the substantia nigra.

  1969cited by this paper
• The effect of brain stem lesions on tyrosine and tryptophan hydroxylases in various structures of the telencephalon of the cat.

  1969cited by this paper
• Electron and fluorescence microscopical studies on the nucleus caudatus putamen of the rat after unilateral lesions of ascending nigro-neostriatal dopamine neurons.

  1969cited by this paper
• Heterogeneous system degeneration. Subcortical argyrophilic dystrophy.

  1969cited by this paper
• Dopamine sites in the basal ganglia.

  1969cited by this paper
• STUDIES OF AMINES IN THE STRIATUM IN MONKEYS WITH NIGRAL LESIONS

  1969cited by this paper
• CONCENTRIC HYALIN INTRANEURONAL INCLUSIONS OF LEWY TYPE IN THE BRAINS OF ELDERLY PERSONS (50 INCIDENTAL CASES): RELATIONSHIP TO PARKINSONISM

  1969cited by this paper
• The nigrostriatal pathway: a correlative study based on neuroanatomical and neurochemical criteria in the cat and the monkey.

  1969cited by this paper
• Effect of interrupting the hypothalamic nervous connections on the norepinephrine and serotonin content of the hypothalamus.

  1969cited by this paper
• Caudate Unit Responses to Nigral Stimuli: Evidence for a Possible Nigro-Neostriatal Pathway

  1968cited by this paper
• Studies on Parkinson's disease including x-ray fluorescent spectroscopy of formalin fixed brain tissue.

  1968cited by this paper
• ["Striato-nigral degeneration"].

  1968cited by this paper
• L-Dopa (L-3,4-dihydroxyphenylanine)--its clinical effects in parkinsonism.

  1968cited by this paper
• Methods of Biochemical Analysis

  1968cited by this paper
• [Neuroaxonal dystrophies].

  1968cited by this paper
• Die Parkinsonsche Krankheit und ihre Behandlung

  1968cited by this paper
• The structure and function of nervous tissue

  1968cited by this paper
• Homovanillic acid in different regions of the human brain: attempt at localizing central dopamine fibres.

  1968cited by this paper
• The efferent projections of the putamen in the monkey.

  1967cited by this paper
• Effect of brain lesions on striatal monoamines in the cat.

  1967cited by this paper
• Methods in medical research

  1967cited by this paper
• Electrophysiological analysis of reciprocal caudato-nigral relations.

  1967cited by this paper
• Homovanillic acid and dihydroxyphenylacetic acid in the striatum of monkeys with brain lesions.

  1967cited by this paper
• Aromatic amino acids and modification of parkinsonism.

  1967cited by this paper
• Effect of amine precursors on the concentration of striatal dopamine and serotonin in cats with and without unilateral brain stem lesions.

  1967cited by this paper
• [On the relations between black substance and the caudate nucleus].

  1967cited by this paper
• Cholinergic-anticholinergic antagonism in parkinsonism.

  1967cited by this paper
• Parkinsonism

  1967cited by this paper
• The effects of ventromedial tegmental lesions on the biosynthesis of catecholamines in the striatum

  1966cited by this paper
• Projections of the lentiform nucleus in the monkey.

  1966cited by this paper
• [The Hallervorden-Spatz Disease].

  1966cited by this paper
• Dopamine (3-hydroxytyramine) and brain function.

  1966cited by this paper
• Criteria for identification of a central nervous system transmitter.

  1966cited by this paper
• Synaptic transmission.

  1966cited by this paper
• A review — critical for idenctification of a central nervous system transmitter

  1966cited by this paper
• Ascending Monoamine Neurons to the Telencephalon and Diencephalon

  1966cited by this paper
• The number of nerve cells in the substantia nigra in paralysis agitans

  1965cited by this paper
• INFLUENCE OF THE SUBSTANTIA NIGRA ON THE CATECHOLAMINE CONTENT OF THE STRIATUM.

  1965cited by this paper
• [Decreased homovanillic acid concentration in the brain in parkinsonian subjects as an expression of a disorder of central dopamine metabolism].

  1965cited by this paper
• The release of dopamine from the putamen

  1965cited by this paper
• Distribution of Homovanillic Acid in the Human Brain

  1964cited by this paper
• Mittenecker, E.: Planung und statistische Auswertung von Experimenten. 4. neubearbeitete und erweiterte Auflage. Franz Deuticke, Wien 1963. 208 Seiten. Preis öS 137,–, DM 22,–

  1964cited by this paper
• Progressive Supranuclear Palsy: A Heterogeneous Degeneration Involving the Brain Stem, Basal Ganglia and Cerebellum With Vertical Gaze and Pseudobulbar Palsy, Nuchal Dystonia and Dementia

  1964cited by this paper
• DEMONSTRATION AND MAPPING OUT OF NIGRO-NEOSTRIATAL DOPAMINE NEURONS.

  1964cited by this paper
• EVIDENCE FOR THE EXISTENCE OF MONOAMINE-CONTAINING NEURONS IN THE CENTRAL NERVOUS SYSTEM. I. DEMONSTRATION OF MONOAMINES IN THE CELL BODIES OF BRAIN STEM NEURONS.

  1964cited by this paper
• DYNAMIC RESPONSE OF CHEST WALL AND LUNG INJURIES IN RABBITS EXPOSED TO AIR SHOCK WAVES OF SHORT DURATION.

  1964cited by this paper
• [INFLUENCE OF LOCUS NIGER ON THE CONCENTRATION OF CATECHOLAMINES IN THE STRIATUM].

  1964cited by this paper
• Observations on the cellular localization of dopamine in the caudate nucleus of the rat

  1964cited by this paper
• EXPERIMENTAL MANGANESE ENCEPHALOPATHY IN MONKEYS: A Preliminary Report

  1963cited by this paper
• A fluorimetric method for the estimation of 4-hydroxy-3-methoxyphenylacetic acid (homovanillic acid) and its identification in brain tissue.

  1963cited by this paper
• Acute Head Injuries

  1963cited by this paper
• Erfahrungen mit L-Dopa in der Therapie des Parkinsonismus

  1963cited by this paper
• On the occurrence of homovanillic acid in brain and cerebrospinal fluid and its determination by a fluorometric method.

  1963cited by this paper
• The basal ganglia and their relation to disorders of movement

  1962cited by this paper
• Topical distribution of the striatal efferents in the monkey

  1962cited by this paper
• [The L-dihydroxyphenylalanine (L-DOPA) effect in Parkinson's syndrome in man: On the pathogenesis and treatment of Parkinson akinesis].

  1962cited by this paper
• The fluorimetric estimation of catecholamines.

  1961cited by this paper
• Determination of catecholamines and catecholamino acids by differential spectrophotofluorimetry.

  1961cited by this paper
• [Distribution of 5-hydroxytryptamine (serotonin) in the human brain and its behavior in patients with Parkinson's syndrome].

  1961cited by this paper
• Occurrence and Localization of Catechol Amines in the Human Brain

  1961cited by this paper
• Determination of catecholamines and catecholamino acids by differential spectrophotofluorimetry.

  1961cited by this paper
• Pathology of Tumours of the Nervous System

  1960cited by this paper
• An experimental study of the course and destination of fibers arising in the head of the caudate nucleus in the cat and monkey

  1960cited by this paper
• Occurrence and distribution of dopamine in brain and other tissues

  1959cited by this paper
• Distribution of catechol compounds in human brain.

  1959cited by this paper
• Staining of glia fibers according to Kanzler

  1956cited by this paper

• Intranasally Delivered Mesenchymal Stem Cells Reverses Prodromal Non-Motor Deficits and Nigral Loss in a Parkinson’s Disease Mouse Model

  2026cites this paper
• Sex-Dependent Dynamics of Behavioural and Neuropathological Changes in an A53T Alpha-Synuclein Mouse Model of Parkinson's Disease.

  2026cites this paper
• Environmental Substances Associated with Neurodegeneration: An Overview of Parkinson's Disease and Related Genotoxic Endpoints.

  2026cites this paper
• De novo identification of potent ingredients for proteasome activation in MT101-5 using an AI-driven approach.

  2026cites this paper
• Cholinergic–dopaminergic interplay underlies prediction error broadcasting

  2026cites this paper
• The lifespan continuum of brain disorders: investigating links between neurodevelopmental and neurodegenerative disease-chicken or egg?

  2026cites this paper
• Behavioral, biochemical, and molecular characterization of MPTP/p-intoxicated mice.

  2025cites this paper
• Vesicular glutamate transporter VGLUT2 expression emerges in substantia nigra dopamine neurons in mouse models of parkinsonism in the absence of neurodegeneration.

  2025cites this paper
• Amyloid‐Inducing Agents via Metabolite Self‐Assembly Expands the Boundary of Prion Concept beyond Proteins

  2025cites this paper
• Bridging the gap in Parkinson’s disease research: from general pathophysiology to advanced 3d cell culture models

  2025cites this paper
• Intranasal delivery of DPSC-derived small extracellular vesicles-encased phloroglucinol attenuates non-motor and motor deficits and promotes neurogenesis in an in vivo rat model of Parkinson’s disease

  2025cites this paper
• Genome‐Wide Association Studies Data and Transcriptomics Data Link Herpes Simplex Virus 1 Infection and Parkinson’s Disease

  2025cites this paper
• Delayed convergence of iterative reconstruction in dopamine transporter SPECT with multiple-pinhole collimators.

  2025cites this paper
• Next generation neural mass model with dopamine modulation mediated by D1-type receptors

  2025cites this paper
• Linguistic changes in spontaneous speech for detecting Parkinson’s disease using large language models

  2025cites this paper
• Longitudinal Serotonergic and Dopaminergic Binding: Impact on Parkinson's Disease Progression and Levodopa Dyskinesia

  2025cites this paper
• The role of aliphatic polyamines and α-synuclein in the formation of peripheral mechanisms involved in the Parkinson’s disease induction

  2025cites this paper
• Fucoxanthinol Mitigates the Cytotoxic Effect of Chlorpyrifos and MPTP on the Dopaminergic Differentiation of SH-SY5Y Human Neuroblastoma Cells

  2025cites this paper
• Bifidobacterium infantis and Bifidobacterium breve Improve Symptomatology and Neuronal Damage in Neurodegenerative Disease: A Systematic Review

  2025cites this paper
• Development of a Visualization-Based Rating Tool for MDS-UPDRS Part III in Core Motion Assessment of Parkinson's Disease

  2025cites this paper
• Striatal spinophilin enhances dopamine D2 receptor (D2R) interaction with cytosolic proteins to mediate persistent D2R agonist-induced locomotor suppression.

  2025cites this paper
• LRRN3 protects dopaminergic neurons by inhibiting glycolysis in Parkinson's disease.

  2025cites this paper
• Dynamical behaviors of the computational model in Parkinsonian state under the effect of electromagnetic induction

  2025cites this paper
• Atomically Dispersed Palladium Supported on Graphene Oxide for Advanced Electrochemical Biosensing of Dopamine

  2025cites this paper
• Beyond neurons: how does dopamine signaling impact astrocytic functions and pathophysiology?

  2025cites this paper
• Fucoxanthin and its metabolite fucoxanthinol alleviate paraquat-induced oxidative damage and neurotoxicity in differentiated human neuroblastoma cells

  2025cites this paper
• An Automatic Rating Approach Using Machine Learning and Feature Selection for Finger Tapping in MDS-UPDRS Part III

  2025cites this paper
• The role of presynaptic dopaminergic imaging in acquired neurological conditions affecting basal ganglia: a systematic review

  2025cites this paper
• Simultaneous Quantification of Biogenic Amines and their Metabolites in Mice Tissue by Combining Ultraviolet and Integrated Pulsed Amperometric Detectors.

  2025cites this paper
• The motor system and motor disorders.

  2025cites this paper
• Cholinergic basal forebrain degeneration in isolated REM sleep behaviour disorder

  2025influential citation
• Effect of the mGlu2 receptor positive allosteric modulator AZD8529 on L-DOPA-induced dyskinesia and psychosis-like behaviours in the parkinsonian marmoset.

  2025cites this paper
• Glucose selective textile OECT based on Molecularly Imprinted Nanoparticles functionalized channel for in vivo plants monitoring

  2025cites this paper
• Nigrostriatal iron accumulation in the progression of Parkinson’s disease

  2025cites this paper
• Striatal spinophilin enhances D2R interaction with cytosolic proteins to mediate persistent D2R agonist-induced locomotor suppression

  2025cites this paper
• Levodopa treatment: impacts and mechanisms throughout Parkinson’s disease progression

  2025influential citation
• Fully automatic categorical analysis of striatal subregions in dopamine transporter SPECT using a convolutional neural network

  2025cites this paper
• Neuroprotective capacity of Celastrus paniculatus on rotenone-induced parkinsonism in zebrafish model

  2025cites this paper
• The Rotenone‐Induced Sporadic Parkinsonism Model: Timeline of Motor and Non‐Motor Features

  2025cites this paper
• Cyclic nucleotide phosphodiesterases as drug targets.

  2025cites this paper
• Pathophysiology of Motor Control Abnormalities in Parkinson's Disease.

  2024cites this paper
• UWB Microwave Functional Brain Activity Extraction for Parkinson’s Disease Monitoring

  2024cites this paper
• Myelin Genes Whose Expression Is Linked with Parkinson’s Disease

  2024cites this paper
• Spatiotemporal neurodegeneration of the substantia nigra and its connecting cortex and subcortex in Parkinson's disease

  2024cites this paper
• Role of Rho-associated kinases and their inhibitor fasudil in neurodegenerative diseases

  2024cites this paper
• Treatments and regulatory mechanisms of acoustic stimuli on mood disorders and neurological diseases

  2024cites this paper
• Dopamine loss alters glutamate synapses and transporters in the medial prefrontal cortex and anxiety‐related behaviour in a male MPTP rodent model of Parkinson's disease

  2024cites this paper
• The Effect of Chronic Treatment with the Inhibitor of Phosphodiesterase 5 (PDE5), Sildenafil, in Combination with L-DOPA on Asymmetric Behavior and Monoamine Catabolism in the Striatum and Substantia Nigra of Unilaterally 6-OHDA-Lesioned Rats

  2024cites this paper
• Unraveling Neuronal Cluster Dynamics in Basal Ganglia Using Hierarchical Drift-Diffusion Modeling

  2024cites this paper
• Houston, We Have AI Problem! Quality Issues with Neuroimaging‐Based Artificial Intelligence in Parkinson's Disease: A Systematic Review

  2024cites this paper
• Neuroimaging Biomarkers in Parkinson's Disease.

  2024cites this paper
• Single-Vesicle Electrochemistry Reveals Polysaccharide from Glochidion eriocarpum Champ. Regulates Vesicular Storage and Exocytotic Release of Dopamine.

  2024cites this paper
• Sex Differences in Parkinson’s Disease: A Narrative Review

  2024cites this paper
• A Deep Brain Stimulation Optimization Strategy Based on Actor-Critic Network

  2024cites this paper
• Itga5-PTEN signaling regulates striatal synaptic strength and motor coordination in Parkinson's disease

  2024cites this paper
• Rethinking Parkinson's disease: could dopamine reduction therapy have clinical utility?

  2024cites this paper
• Moderate intensity aerobic exercise alleviates motor deficits in 6-OHDA lesioned rats and reduces serum levels of biomarkers of Parkinson's disease severity without recovery of striatal dopamine or tyrosine hydroxylase.

  2024cites this paper
• Emergence of pathological beta oscillation and its uncertainty quantification in a time-delayed feedback Parkinsonian model

  2024cites this paper
• A simulation study of transcranial magnetoacoustic stimulation of the basal ganglia thalamic neural network to improve pathological beta oscillations in Parkinson's disease

  2024cites this paper
• In and out: Benchmarking in vitro, in vivo, ex vivo, and xenografting approaches for an integrative brain disease modeling pipeline

  2024cites this paper
• Effect of the mGlu2 positive allosteric modulator biphenyl‐indanone A as a monotherapy and as adjunct to a low dose of L‐DOPA in the MPTP‐lesioned marmoset

  2024cites this paper
• Regulation of Keap1-Nrf2 signaling in health and diseases

  2024cites this paper
• Enhanced cognitive flexibility and phasic striatal dopamine dynamics in a mouse model of low striatal tonic dopamine

  2024cites this paper
• Systematic analysis of multi-omics data reveals component-specific blood-based biomarkers for Parkinson’s disease

  2024cites this paper
• A voltammetric method coupled with chemometrics for determination of a ternary antiparkinson mixture in its dosage form: greenness assessment

  2024cites this paper
• Towards a biological diagnosis of PD.

  2024cites this paper
• Combining physical & cognitive training with iPSC-derived dopaminergic neuron transplantation promotes graft integration & better functional outcome in parkinsonian marmosets.

  2024cites this paper
• Aquaporin-4 and Parkinson’s Disease

  2024cites this paper
• Effects of latroeggtoxin-VI on dopamine and α-synuclein in PC12 cells and the implications for Parkinson’s disease

  2024cites this paper
• Unraveling the Ties: Type 2 Diabetes and Parkinson's Disease - A Nano-Based Targeted Drug Delivery Approach.

  2024cites this paper
• Cross-Spatiotemporal Graph Convolution Networks for Skeleton-Based Parkinsonian Gait MDS-UPDRS Score Estimation

  2024cites this paper
• Initial Molecular Mechanisms of the Pathogenesis of Parkinson’s Disease in a Mouse Neurotoxic Model of the Earliest Preclinical Stage of This Disease

  2024cites this paper
• Systemic inflammation accelerates neurodegeneration in a rat model of Parkinson’s disease overexpressing human alpha synuclein

  2024cites this paper
• Nanocarriers to mediate the pathways from diabetes toward Parkinson's disease

  2024cites this paper
• OLFACTORY tract/BULB metal CONCENTRATION in Manganese-EXPOSED mineWORKErs.

  2024cites this paper
• Linguistic Changes in Spontaneous Speech for Detecting Parkinsons Disease Using Large Language Models

  2024cites this paper
• Structural underpinnings and long-term effects of resilience in Parkinson’s disease

  2024cites this paper
• Adenosine A2A Receptor Blockade Provides More Effective Benefits at the Onset Rather than after Overt Neurodegeneration in a Rat Model of Parkinson’s Disease

  2024cites this paper
• Dopaminergic changes in the subgenual cingulate cortex in dementia with lewy bodies associates with presence of depression

  2024cites this paper
• Oxidation of dopamine and related catechols in dopaminergic brain regions in Parkinson’s disease and during ageing in non-Parkinsonian subjects

  2024cites this paper
• Antinociceptive role of the thalamic dopamine D3 receptor in descending modulation of intramuscular formalin-induced muscle nociception in a rat model of Parkinson's disease.

  2024cites this paper
• L-Dopa-induced changes in aperiodic bursts dynamics relate to individual clinical improvement in Parkinson’s disease

  2024cites this paper
• Dopamine Signaling in Substantia Nigra and Its Impact on Locomotor Function—Not a New Concept, but Neglected Reality

  2024cites this paper
• Extracellular Vesicles as Biomarkers for Parkinson’s Disease: How Far from Clinical Translation?

  2024cites this paper
• Rodent Models of Alzheimer’s Disease: Past Misconceptions and Future Prospects

  2024cites this paper
• Olfactory Projections to Locomotor Control Centers in the Sea Lamprey

  2024cites this paper
• Pathological Correlates of Cognitive Decline in Parkinson’s Disease: From Molecules to Neural Networks

  2023cites this paper
• Differential Effects of Paraquat, Rotenone, and MPTP on Cellular Bioenergetics of Undifferentiated and Differentiated Human Neuroblastoma Cells

  2023cites this paper
• Age-Dependent Modulation of Layer V Pyramidal Neuron Excitability in the Mouse Primary Motor Cortex by D1 Receptor Agonists and Antagonists.

  2023cites this paper
• Dynamical questions in volume transmission

  2023cites this paper
• An Adverse Outcome Pathway for Chemical-induced Parkinson's disease: Calcium is Key.

  2023cites this paper
• Behavioral, neural and ultrastructural alterations in a graded-dose 6-OHDA mouse model of early-stage Parkinson's disease

  2023cites this paper
• Nigral-specific increase in ser31 phosphorylation compensates for tyrosine hydroxylase protein and nigrostriatal neuron loss: Implications for delaying parkinsonian signs.

  2023cites this paper
• Locomotor Behavior and Memory Dysfunction Induced by 3-Nitropropionic Acid in Adult Zebrafish: Modulation of Dopaminergic Signaling

  2023cites this paper
• Beyond Motor Deficits: Environmental Enrichment Mitigates Huntington’s Disease Effects in YAC128 Mice

  2023cites this paper
• Scalable, flexible carbon fiber electrode thread arrays for three-dimensional probing of neurochemical activity in deep brain structures of rodents.

  2023cites this paper
• Cotransplantation of NSCs and ethyl stearate promotes synaptic plasticity in PD rats by Drd1/ERK/AP-1 signaling pathway.

  2023cites this paper
• Local field potential (LFP) power and phase-amplitude coupling (PAC) changes in the striatum and motor cortex reflect neural mechanisms associated with bradykinesia and rigidity during D2R suppression in an animal model.

  2023cites this paper
• Recovery of motor function is associated with rescue of glutamate biomarkers in the striatum and motor cortex following treatment with Mucuna pruriens in a murine model of Parkinson's disease.

  2023cites this paper
• Transient exposure to rotenone causes degeneration and progressive parkinsonian motor deficits, neuroinflammation, and synucleinopathy

  2023cites this paper